Douglas will have left a sour taste for those investors who have lost money and could be a drag for some IPO candidates.

We and re still in the recovery phase, so we and re not in an anything goes environment but a selective environment, said Martin Thorneycroft, head of cash ECM in EMEA at Morgan Stanley, which co-led the Galderma IPO. continuă pe Ziarul Bursa